Clinical Trial Update: Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

View source ↗

Summary

An observational program in the Russian Federation evaluated routine use of add-back therapy with Lucrin Depot (leuprorelin) for endometriosis over a planned 6-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Lucrin Depot (Leuprorelin)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Genital Endometriosis | Status: COMPLETED | Results posted: 2013-07-22